Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy.
Dercle L, Ammari S, Roblin E, Bigorgne A, Champiat S, Taihi L, Plaian A, Hans S, Lakiss S, Tselikas L, Rouanne M, Deutsch E, Schwartz LH, Gönen M, Flynn J, Massard C, Soria JC, Robert C, Marabelle A. Dercle L, et al. Among authors: rouanne m. Eur J Cancer. 2022 Dec;177:80-93. doi: 10.1016/j.ejca.2022.08.034. Epub 2022 Sep 30. Eur J Cancer. 2022. PMID: 36332438
Rationale for LDH-targeted cancer immunotherapy.
Miholjcic TBS, Halse H, Bonvalet M, Bigorgne A, Rouanne M, Dercle L, Shankar V, Marabelle A. Miholjcic TBS, et al. Among authors: rouanne m. Eur J Cancer. 2023 Mar;181:166-178. doi: 10.1016/j.ejca.2022.11.032. Epub 2022 Dec 14. Eur J Cancer. 2023. PMID: 36657325 Free article. Review.
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology.
Neuzillet Y, Methorst C, Schneider M, Lebret T, Rouanne M, Radulescu C, Molinie V, Dreyfus JF, Pelcat V, Botto H. Neuzillet Y, et al. Among authors: rouanne m. Urol Oncol. 2014 Nov;32(8):1135-40. doi: 10.1016/j.urolonc.2014.04.005. Epub 2014 Jul 9. Urol Oncol. 2014. PMID: 25023786 Clinical Trial.
Novel therapeutic targets in advanced urothelial carcinoma.
Rouanne M, Loriot Y, Lebret T, Soria JC. Rouanne M, et al. Crit Rev Oncol Hematol. 2016 Feb;98:106-15. doi: 10.1016/j.critrevonc.2015.10.021. Epub 2015 Nov 9. Crit Rev Oncol Hematol. 2016. PMID: 26589398 Review.
83 results